Cargando…

Natural killer cells for cancer immunotherapy: a new CAR is catching up

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355444/ https://www.ncbi.nlm.nih.gov/pubmed/30685121 http://dx.doi.org/10.1016/j.ebiom.2019.01.018

Ejemplares similares

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Special Issue “New Developments in Natural Killer Cells for Immunotherapy”
por: Zimmer, Jacques, et al.
Publicado: (2023)

The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
por: Simon, Bianca, et al.
Publicado: (2018)

New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
por: Teyton, Luc
Publicado: (2017)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Are natural killer cells superior CAR drivers?
por: Klingemann, Hans
Publicado: (2014)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Childhood vaccinations: playing catch-up
por: The Lancet Child & Adolescent Health
Publicado: (2021)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

Advantages and applications of CAR-expressing natural killer cells
por: Glienke, Wolfgang, et al.
Publicado: (2015)

Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Natural killer cells: a promising immunotherapy for cancer
por: Chu, Junfeng, et al.
Publicado: (2022)

Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
por: Zhang, Minchuan, et al.
Publicado: (2023)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
por: El Assal, Rami, et al.
Publicado: (2019)

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
por: Rezvani, Katayoun, et al.
Publicado: (2015)

Pharmacological targeting of natural killer cells for cancer immunotherapy
por: Miyazato, Kiho, et al.
Publicado: (2020)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
por: Shaver, Kari A., et al.
Publicado: (2021)

Natural killer cells: the next wave in cancer immunotherapy
por: Chen, Xin, et al.
Publicado: (2022)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019)

Inequality in Immunization: Holding on to Equity as We ‘Catch Up’
por: Nambiar, Devaki, et al.
Publicado: (2023)

Programming a serial killer: CAR T cells form non-classical immune synapses
por: Davenport, Alexander J, et al.
Publicado: (2018)

A Hot Topic: Cancer Immunotherapy and Natural Killer Cells
por: Michel, Tatiana, et al.
Publicado: (2022)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Natural Killer Cells: Angels and Devils for Immunotherapy
por: Martín-Antonio, Beatriz, et al.
Publicado: (2017)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Natural Killer Cell-Mediated Immunotherapy for Leukemia
por: Allison, Michaela, et al.
Publicado: (2022)

Catch-Up Growth in Former Preterm Neonates: No Time to Waste
por: Raaijmakers, Anke, et al.
Publicado: (2016)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
por: Zhao, Xiaoyan, et al.
Publicado: (2020)

iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
por: Karagiannis, Peter, et al.
Publicado: (2021)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
por: Poon, Angie Yu Ching, et al.
Publicado: (2022)

DNAM-1: would the real natural killer cell please stand up!
por: Huntington, Nicholas D., et al.
Publicado: (2015)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_be3rln42da52kold5kpp1r2ud6